MetaVia’s DA-1726 Shows Robust Weight and Liver Benefits in Phase 1 Study—Could This Be a Step Forward for Obesity and MASH?
Market Chameleon (Wed, 27-May 11:07 AM)
Peer-Reviewed Evidence Highlights Vanoglipel’s Promise in Tackling Liver Fibrosis and MASH
Market Chameleon (Wed, 20-May 10:33 AM)
